Fulcrum Therapeutics at H.C. Wainwright: Posiradir's Promise for Sickle Cell

Related
First Trust Income Opportunities ETF declares $0.135 dividen...
7 minutes ago
0
Inflation shoots higher as Trump tariffs ripple through econ...
8 minutes ago
0
First Trust Enhanced Equity Income Fund raises dividend by 1...
9 minutes ago
0
UPS and FedEx see rating cuts at BofA due to concerns of mut...
9 minutes ago
0
XPEL acquires assets of exclusive aftermarket distributor in...
9 minutes ago
0
Auto leaders hail GST cuts as boost for car buyers, see fest...
10 minutes ago
0
PACS Group announces NYSE listing extension
11 minutes ago
0
4 stocks to watch on Thursday: ADBE, KR, NBIS, CARR
11 minutes ago
0
Empire Non-GAAP EPS of $0.90, revenue of $8.25M
12 minutes ago
0
FOXO to buy Vector Biosource
16 minutes ago
0
ADF Group GAAP EPS of $0.03, revenue of $53M
16 minutes ago
0
SoundHound initiated with Perform rating at Oppenheimer
18 minutes ago
0
Citi expects Micron to report much stronger-than-expected gu...
22 minutes ago
0
CPI read: Egg prices remain elevated amid avian influenza ba...
23 minutes ago
0
Zupee to lay off 170 employees after real-money gaming ban
24 minutes ago
0
GCT Semiconductor announces $10.7M debt financing
26 minutes ago
0
Cohen & Steers Infrastructure Fund declares $0.155 dividend
26 minutes ago
0
PM Modi to launch portal on manuscript digitisation tomorrow...
28 minutes ago
0
CPI read: Airfares jump higher in August amid solid booking ...
28 minutes ago
0
TPG to acquire GE Vernova’s Proficy software unit for $600M
29 minutes ago
0